Quick Answer
Coherus Oncology, Inc. reported Total Assets of $258.34 million for fiscal year 2025.
Coherus Oncology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $258.34M | -42.4% |
| 2024 | $448.53M | -28.8% |
| 2023 | $629.60M | +30.9% |
| 2022 | $480.85M | -29.2% |
| 2021 | $679.33M | -19.3% |
| 2020 | $841.65M | +105.8% |
| 2019 | $408.93M | +311.1% |
| 2018 | $99.47M | -38.8% |
| 2017 | $162.61M | -8.9% |
| 2016 | $178.49M | -16.0% |
| 2015 | $212.38M | +13.4% |
| 2014 | $187.22M | +294.6% |
| 2013 | $47.45M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $516.52M | +2.3% | +17.5% |
| June 30, 2025 | $439.46M | -34.9% | +18.4% |
| March 31, 2025 | $371.07M | -51.4% | -17.3% |
| December 31, 2024 | $448.53M | -28.8% | -11.2% |
| September 30, 2024 | $505.00M | -13.5% | -25.2% |
| June 30, 2024 | $674.86M | +43.7% | -11.6% |
| March 31, 2024 | $763.54M | +89.7% | +21.3% |
| December 31, 2023 | $629.60M | +30.9% | +7.8% |
- Coherus Oncology, Inc. showed a decrease of -42.4% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Coherus Oncology, Inc.’s total assets has grown by 444.5% (from $47.45 million to $258.34 million).
- The most recent figure is from Coherus Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: